C & F Financial Corp 8-K, filed Jul 20, 2022
C & F Financial Corp (CFFI)
About this 8-K
C & F Financial Corp filed this 8-K on July 20, 2022, reporting on events of July 19, 2022.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
| | |||
(State or other jurisdiction of | | (Commission | | (IRS Employer |
| ||
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code (
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange of 1934 (§240.12b-2 of this chapter).
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On July 19, 2022, Dr. Julie Agnew notified C&F Financial Corporation (the “Corporation”) of her resignation from the Board of Directors (the “Board”) of the Corporation, effective August 16, 2022. Dr. Agnew informed the board that she has accepted an offer of employment with an investment manager which precludes her service as a director for any company whose stock is publicly traded and that her resignation is not the result of a disagreement with the Corporation on any matter relating to the Corporation’s operations, policies, or practices. The Corporation is grateful for Dr. Agnew’s contributions as a valuable member of the Board since 2017. Dr. Agnew has also served on the board of directors of Citizens and Farmers Bank, the Corporation’s commercial banking subsidiary, since 2016 and has served as a member of the Board’s Audit Committee and Nominating Committee.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| C&F FINANCIAL CORPORATION | |
| | | | (Registrant) | |
| | | | | |
| | | | | |
Date: | July 19, 2022 | | | By: | /s/ Jason E. Long |
| | | | | Jason E. Long |
| | | | | Chief Financial Officer and Secretary |
3